Colchicine Levels in the Serum of FMF (Familial Mediterranean Fever) Patients
NCT03210610 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2018-04-20
Summary
in this study the investigators will measure the colchicine trough levels in 80 FMF patients taking stable doses of colchicine
Conditions
- FMF
- Colchicine Resistance
- Colchicine Toxicity
Interventions
- DIAGNOSTIC_TEST
-
colchicine level measurement
levels of colchicine will be measured in FMF patients taking colchicine
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Principal Investigators
-
merav lidar, prof · Sheba Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-19
- Primary Completion
- 2020-07-15
- Completion
- 2020-07-15
Countries
- Israel
Study Locations
More Related Trials
-
Study of Colchicine Resistance in Familial Mediterranean Fever
NCT05418686 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine
NCT05092776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever
NCT01088880 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy
NCT06336733 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical and Molecular Evaluation of Childern With Familial Meditterranean Fever and Their Siblings
NCT05488561 ·Status: UNKNOWN ·Phase: NA
-
FMF and Atheroscelerosis
NCT06047938 ·Status: NOT_YET_RECRUITING
-
Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission
NCT00323440 ·Status: WITHDRAWN
-
A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF
NCT06666335 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Colchicine for Patients With Chagas´ Disease( B1 Stage)
NCT03704181 ·Status: UNKNOWN ·Phase: PHASE2
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis
NCT04244916 ·Status: TERMINATED
-
Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease
NCT00700297 ·Status: COMPLETED ·Phase: PHASE2
-
Mobile App-Based Infection Monitoring in Familial Mediterranean Fever
NCT07212764 ·Status: ENROLLING_BY_INVITATION
-
A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis
NCT06335888 ·Status: RECRUITING ·Phase: PHASE2
-
An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes
NCT02911857 ·Status: COMPLETED ·Phase: PHASE3
-
Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)
NCT00981838 ·Status: COMPLETED ·Phase: PHASE3
-
Health-related Quality of Life, Electrocardiographic and Holter Findings in Children With Familial Mediterranean Fever
NCT07128225 ·Status: ACTIVE_NOT_RECRUITING
-
The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients
NCT01854814 ·Status: COMPLETED ·Phase: NA
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Immun Response in Children With MIS-C
NCT05052424 ·Status: UNKNOWN
-
Treatment With High Dose Methotrexate in Patients With Eosinophilic Fasciitis
NCT00441961 ·Status: COMPLETED ·Phase: NA
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
NETs Formation in Patients With Recurrent Pyogenic Infections (NETS)
NCT01112592 ·Status: UNKNOWN
-
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
NCT02592798 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study
NCT05074706 ·Status: COMPLETED